Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut CREBBP 1387 broad.mit.edu 37 16 3781375 3781375 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr16:3781375G>A ENST00000262367.5 - 30 5799 c.4990C>T c.(4990-4992)Cgc>Tgc p.R1664C CREBBP_ENST00000382070.3_Missense_Mutation_p.R1626C NM_004380.2 NP_004371.2 Q92793 CBP_HUMAN CREB binding protein 1664 Interaction with TRERF1. R -> H (in RSTS1; abolishes acetyltransferase activity). cellular lipid metabolic process|homeostatic process|interspecies interaction between organisms|N-terminal peptidyl-lysine acetylation|protein complex assembly|response to hypoxia cytoplasm|nuclear body histone acetyltransferase activity|MyoD binding|p53 binding|sequence-specific DNA binding transcription factor activity|signal transducer activity|transcription coactivator activity|zinc ion binding p.R1664C(1) NS(1)|breast(5)|central_nervous_system(4)|cervix(3)|endometrium(12)|haematopoietic_and_lymphoid_tissue(125)|kidney(5)|large_intestine(32)|lung(43)|ovary(18)|pancreas(2)|prostate(6)|skin(9)|soft_tissue(1)|stomach(3)|upper_aerodigestive_tract(5)|urinary_tract(21) 295 Ovarian(90;0.0266) OV - Ovarian serous cystadenocarcinoma(1;3.54e-05) AAGGCGTCGCGCCCATCCATG 0.642000 """T, N, F, Mis, O""" """MLL, MORF, RUNXBP2""" """ALL, AML, DLBCL, B-NHL """ Rubinstein-Taybi syndrome 6 17 0 0 1 0 0 TGM7 116179 broad.mit.edu 37 15 43574758 43574758 + Silent SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr15:43574758G>A ENST00000452443.2 - 8 1069 c.1065C>T c.(1063-1065)aaC>aaT p.N355N NM_052955.2 NP_443187.1 Q96PF1 TGM7_HUMAN transglutaminase 7 355 peptide cross-linking acyltransferase activity|metal ion binding|protein-glutamine gamma-glutamyltransferase activity breast(2)|central_nervous_system(1)|cervix(1)|endometrium(1)|kidney(3)|large_intestine(8)|lung(16)|ovary(2)|prostate(4)|skin(1) 39 all_cancers(109;2.12e-14)|all_epithelial(112;1.99e-12)|Lung NSC(122;2.46e-08)|all_lung(180;2.75e-07)|Melanoma(134;0.0476)|Colorectal(260;0.215) GBM - Glioblastoma multiforme(94;9.14e-07) L-Glutamine(DB00130) CCTGCCACCCGTTGTATCCTG 0.562000 3 6 0 0 1 0 0 RNF175 285533 broad.mit.edu 37 4 154636798 154636798 + Missense_Mutation SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr4:154636798C>T ENST00000274068.4 - 6 639 c.263G>A c.(262-264)cGg>cAg p.R88Q RNF175_ENST00000347063.4_Missense_Mutation_p.R216Q Q8N4F7 RN175_HUMAN ring finger protein 175 216 integral to membrane zinc ion binding breast(1)|endometrium(1)|large_intestine(5)|lung(1)|ovary(1)|pancreas(1)|prostate(2)|upper_aerodigestive_tract(1) 13 all_hematologic(180;0.093) Renal(120;0.118) TGTAGGCAACCGGCTGACACT 0.502000 10 18 0 0 1 0 0 IQGAP3 128239 broad.mit.edu 37 1 156499981 156499981 + Silent SNP G G C TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr1:156499981G>C ENST00000361170.2 - 34 4330 c.4320C>G c.(4318-4320)gtC>gtG p.V1440V NM_178229.4 NP_839943.2 Q86VI3 IQGA3_HUMAN IQ motif containing GTPase activating protein 3 1440 small GTPase mediated signal transduction intracellular calmodulin binding|Ras GTPase activator activity NS(1)|breast(2)|central_nervous_system(1)|endometrium(8)|kidney(2)|large_intestine(14)|lung(29)|ovary(5)|prostate(5)|skin(5)|urinary_tract(3) 75 all_hematologic(923;0.088)|Hepatocellular(266;0.158) GGTTCCGCAGGACGCGCCGCT 0.647000 6 11 0 0 1 0 0 SPATA2 9825 broad.mit.edu 37 20 48522793 48522793 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr20:48522793G>A ENST00000422556.1 - 3 1275 c.926C>T c.(925-927)cCg>cTg p.P309L SPATA2_ENST00000543716.1_Missense_Mutation_p.P172L|SPATA2_ENST00000289431.5_Missense_Mutation_p.P309L NM_001135773.1 NP_001129245.1 Q9UM82 SPAT2_HUMAN spermatogenesis associated 2 309 cell differentiation|multicellular organismal development|spermatogenesis cytoplasm|nucleus central_nervous_system(1)|endometrium(2)|large_intestine(3)|lung(11)|ovary(1)|prostate(1)|skin(1) 20 Hepatocellular(150;0.133) BRCA - Breast invasive adenocarcinoma(9;4.03e-06) AAGCACATCCGGGCTGCCGTG 0.637000 30 65 0 0 1 0 0 IMPDH2 3615 broad.mit.edu 37 3 49065256 49065256 + Missense_Mutation SNP A A T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr3:49065256A>T ENST00000326739.4 - 5 457 c.418T>A c.(418-420)Tgc>Agc p.C140S NM_000884.2 NP_000875.2 P12268 IMDH2_HUMAN IMP (inosine 5'-monophosphate) dehydrogenase 2 140 CBS 1. GMP biosynthetic process|purine base metabolic process cytosol|nucleus IMP dehydrogenase activity|metal ion binding|nucleotide binding|protein binding breast(2)|endometrium(3)|kidney(1)|large_intestine(6)|lung(2)|stomach(1)|urinary_tract(1) 16 BRCA - Breast invasive adenocarcinoma(193;8.01e-05)|Kidney(197;0.00216)|KIRC - Kidney renal clear cell carcinoma(197;0.00244) Mycophenolate mofetil(DB00688)|Mycophenolic acid(DB01024)|NADH(DB00157) GGGATACCGCAGAAACCATGC 0.542000 15 43 0 0 1 0 0 TRPM2 7226 broad.mit.edu 37 21 45817649 45817649 + Missense_Mutation SNP C C T rs149619816 byFrequency TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr21:45817649C>T ENST00000397928.1 + 13 2397 c.1952C>T c.(1951-1953)gCg>gTg p.A651V TRPM2_ENST00000498430.1_3'UTR|TRPM2_ENST00000300482.5_Missense_Mutation_p.A651V|TRPM2_ENST00000300481.9_Missense_Mutation_p.A631V|TRPM2_ENST00000397932.2_Missense_Mutation_p.A651V NM_003307.3 NP_003298.1 O94759 TRPM2_HUMAN transient receptor potential cation channel, subfamily M, member 2 651 integral to plasma membrane ADP-ribose diphosphatase activity|calcium channel activity|sodium channel activity breast(3)|central_nervous_system(2)|endometrium(4)|kidney(3)|large_intestine(15)|lung(29)|ovary(3)|pancreas(1)|prostate(5)|skin(7)|upper_aerodigestive_tract(3)|urinary_tract(1) 76 TGCATCGCAGCGGCCTTGGCC 0.622000 7 17 0 0 1 0 0 SHD 56961 broad.mit.edu 37 19 4284902 4284902 + Splice_Site SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr19:4284902G>A ENST00000543264.2 + 4 2179 c.e4+1 SHD_ENST00000600475.1_Splice_Site|SHD_ENST00000599689.1_Splice_Site NM_020209.3 NP_064594.3 Q96IW2 SHD_HUMAN Src homology 2 domain containing transforming protein D breast(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(5)|stomach(1) 14 UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|BRCA - Breast invasive adenocarcinoma(158;0.0337)|STAD - Stomach adenocarcinoma(1328;0.18) AGAAACAGCCGTGAGTGGGGA 0.587000 23 43 0 0 1 0 0 TTN 7273 broad.mit.edu 37 2 179443857 179443857 + Missense_Mutation SNP C C G TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr2:179443857C>G ENST00000589042.1 - 320 68124 c.67900G>C c.(67900-67902)Gga>Cga p.G22634R TTN-AS1_ENST00000456053.1_RNA|TTN-AS1_ENST00000419746.1_RNA|TTN-AS1_ENST00000586707.1_RNA|TTN-AS1_ENST00000586452.1_RNA|TTN-AS1_ENST00000585451.1_RNA|TTN-AS1_ENST00000592630.1_RNA|TTN_ENST00000460472.2_Missense_Mutation_p.G13569R|RP11-171I2.2_ENST00000603521.1_RNA|TTN_ENST00000359218.5_Missense_Mutation_p.G13694R|TTN-AS1_ENST00000592750.1_RNA|TTN-AS1_ENST00000592689.1_RNA|TTN-AS1_ENST00000438095.1_RNA|TTN-AS1_ENST00000592600.1_RNA|TTN_ENST00000342992.6_Missense_Mutation_p.G20066R|TTN-AS1_ENST00000591332.1_RNA|TTN_ENST00000591111.1_Missense_Mutation_p.G20993R|TTN-AS1_ENST00000590932.1_RNA|TTN-AS1_ENST00000590807.1_RNA|TTN_ENST00000342175.6_Missense_Mutation_p.G13761R|TTN-AS1_ENST00000586831.1_RNA NM_001267550.1 NP_001254479.1 Q8WZ42 TITIN_HUMAN titin 20993 Fibronectin type-III 64. ATP binding|nucleic acid binding|protein serine/threonine kinase activity|protein tyrosine kinase activity NS(24)|autonomic_ganglia(1)|breast(64)|central_nervous_system(14)|cervix(14)|endometrium(96)|haematopoietic_and_lymphoid_tissue(16)|kidney(91)|large_intestine(303)|liver(1)|lung(595)|ovary(58)|pancreas(17)|prostate(38)|skin(60)|stomach(29)|upper_aerodigestive_tract(1)|urinary_tract(26) 1448 OV - Ovarian serous cystadenocarcinoma(117;0.023)|Epithelial(96;0.0454)|all cancers(119;0.134) GAGATAGTTCCTTCCTTGGTG 0.443000 11 34 0 0 1 0 0 BOD1L1 259282 broad.mit.edu 37 4 13600828 13600828 + Missense_Mutation SNP T T C TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr4:13600828T>C ENST00000040738.5 - 10 7831 c.7696A>G c.(7696-7698)Agt>Ggt p.S2566G NM_148894.2 NP_683692.2 Q8NFC6 BOD1L_HUMAN biorientation of chromosomes in cell division 1-like 1 2566 DNA binding TTGGTGGTACTGGTTTTCAAG 0.468000 OREG0016115 type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip) 8 11 0 0 1 0 0 OBSCN 84033 broad.mit.edu 37 1 228461596 228461596 + Translation_Start_Site SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr1:228461596G>A ENST00000366707.4 + 0 5307 OBSCN_ENST00000284548.11_Missense_Mutation_p.D1755N|OBSCN_ENST00000570156.2_Missense_Mutation_p.D2130N|OBSCN_ENST00000366709.4_De_novo_Start_OutOfFrame|RP5-1139B12.2_ENST00000602517.1_RNA|OBSCN_ENST00000359599.6_Missense_Mutation_p.D602N|OBSCN_ENST00000422127.1_Missense_Mutation_p.D1755N Q5VST9 OBSCN_HUMAN obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF apoptosis|cell differentiation|induction of apoptosis by extracellular signals|multicellular organismal development|nerve growth factor receptor signaling pathway|regulation of Rho protein signal transduction|small GTPase mediated signal transduction cytosol|M band|Z disc ATP binding|metal ion binding|protein binding|protein serine/threonine kinase activity|protein tyrosine kinase activity|Rho guanyl-nucleotide exchange factor activity|structural constituent of muscle|titin binding NS(2)|breast(7)|central_nervous_system(5)|cervix(2)|endometrium(30)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(37)|lung(89)|ovary(8)|pancreas(3)|prostate(13)|skin(6)|stomach(11)|upper_aerodigestive_tract(2)|urinary_tract(3) 223 Prostate(94;0.0405) CTGGCTCAAGGATGGTGTGGA 0.647000 8 9 0 0 1 0 0 KIAA1244 57221 broad.mit.edu 37 6 138601169 138601169 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr6:138601169G>A ENST00000251691.4 + 14 2495 c.2329G>A c.(2329-2331)Gtg>Atg p.V777M NM_020340.4 NP_065073.3 Q5TH69 BIG3_HUMAN KIAA1244 777 SEC7. regulation of ARF protein signal transduction cytoplasm|integral to membrane ARF guanyl-nucleotide exchange factor activity NS(1)|breast(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(11)|lung(17)|ovary(2)|skin(2) 44 Breast(32;0.135) OV - Ovarian serous cystadenocarcinoma(155;0.00102)|GBM - Glioblastoma multiforme(68;0.00259) GACCAGCGGCGTGCTGATGGT 0.547000 17 26 0 0 1 0 0 SRBD1 55133 broad.mit.edu 37 2 45620175 45620175 + Silent SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr2:45620175C>T ENST00000263736.4 - 20 2669 c.2607G>A c.(2605-2607)gaG>gaA p.E869E SRBD1_ENST00000535761.1_Silent_p.E388E|SRBD1_ENST00000490133.1_5'UTR NM_018079.4 NP_060549.4 Q8N5C6 SRBD1_HUMAN S1 RNA binding domain 1 869 nucleobase, nucleoside, nucleotide and nucleic acid metabolic process hydrolase activity, acting on ester bonds|RNA binding NS(1)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(13)|large_intestine(8)|lung(15)|skin(2)|stomach(1)|urinary_tract(1) 49 all_hematologic(82;0.166)|Acute lymphoblastic leukemia(82;0.17) LUSC - Lung squamous cell carcinoma(58;0.0917)|Lung(47;0.154) CTGCAATTTTCTCCATTCCTT 0.403000 26 40 0 0 1 0 0 FAIM 55179 broad.mit.edu 37 3 138341217 138341217 + Nonsense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr3:138341217G>A ENST00000338446.4 + 4 1084 c.401G>A c.(400-402)tGg>tAg p.W134* FAIM_ENST00000393034.2_Nonsense_Mutation_p.W100*|FAIM_ENST00000464668.1_Nonsense_Mutation_p.W100*|FAIM_ENST00000360570.3_Nonsense_Mutation_p.W122*|FAIM_ENST00000393035.2_Nonsense_Mutation_p.W100* NM_001033030.1 NP_001028202.1 Q9NVQ4 FAIM1_HUMAN Fas apoptotic inhibitory molecule 100 apoptosis cytoplasm kidney(1)|upper_aerodigestive_tract(1) 2 ACCAATACTTGGGTATTACAC 0.333000 14 24 0 0 1 0 0 LAMA5 3911 broad.mit.edu 37 20 60895628 60895628 + Missense_Mutation SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr20:60895628C>T ENST00000252999.3 - 50 6812 c.6746G>A c.(6745-6747)cGg>cAg p.R2249Q NM_005560.3 NP_005551.3 O15230 LAMA5_HUMAN laminin, alpha 5 2249 Domain II and I. angiogenesis|cell proliferation|cell recognition|cytoskeleton organization|endothelial cell differentiation|focal adhesion assembly|integrin-mediated signaling pathway|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|substrate adhesion-dependent cell spreading extracellular space|laminin-1 complex|laminin-10 complex|laminin-11 complex integrin binding breast(2)|central_nervous_system(3)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(3)|kidney(7)|lung(40)|ovary(1)|pancreas(1)|prostate(3)|skin(6)|stomach(1)|upper_aerodigestive_tract(5)|urinary_tract(2) 81 Breast(26;1.57e-08) BRCA - Breast invasive adenocarcinoma(19;4.36e-06) Alteplase(DB00009)|Anistreplase(DB00029)|Reteplase(DB00015)|Tenecteplase(DB00031) GCCGCCTAGCCGCCGTGCGTC 0.687000 4 6 0 0 1 0 0 PRDM9 56979 broad.mit.edu 37 5 23522989 23522989 + Missense_Mutation SNP T T A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr5:23522989T>A ENST00000296682.3 + 8 1059 c.877T>A c.(877-879)Tgg>Agg p.W293R NM_020227.2 NP_064612.2 Q9NQV7 PRDM9_HUMAN PR domain containing 9 293 SET. meiosis|regulation of transcription, DNA-dependent|transcription, DNA-dependent chromosome|nucleoplasm histone-lysine N-methyltransferase activity|nucleic acid binding|zinc ion binding NS(1)|breast(1)|central_nervous_system(3)|endometrium(15)|haematopoietic_and_lymphoid_tissue(3)|kidney(2)|large_intestine(27)|lung(87)|ovary(6)|pancreas(2)|prostate(4)|skin(10)|upper_aerodigestive_tract(11) 172 TGGATACTCCTGGCTGGTAAG 0.493000 HNSCC(3;0.000094) 19 48 0 0 1 0 0 C5 727 broad.mit.edu 37 9 123812513 123812513 + Silent SNP C C T rs35352264 byFrequency TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr9:123812513C>T ENST00000223642.1 - 1 41 c.12G>A c.(10-12)ttG>ttA p.L4L NM_001735.2 NP_001726.2 P01031 CO5_HUMAN complement component 5 4 activation of MAPK activity|chemotaxis|complement activation, alternative pathway|complement activation, classical pathway|cytolysis|G-protein coupled receptor protein signaling pathway|inflammatory response|negative regulation of macrophage chemotaxis|positive regulation of chemokine secretion|positive regulation vascular endothelial growth factor production extracellular space|membrane attack complex chemokine activity|endopeptidase inhibitor activity breast(1)|central_nervous_system(2)|cervix(1)|endometrium(7)|kidney(2)|large_intestine(14)|lung(5)|ovary(2)|prostate(4)|skin(4)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(1) 46 OV - Ovarian serous cystadenocarcinoma(323;4.98e-53)|GBM - Glioblastoma multiforme(294;0.0242) Eculizumab(DB01257) AAAGTATTCCCAAAAGGCCCA 0.373000 19 44 0 0 1 0 0 HHIP 64399 broad.mit.edu 37 4 145636526 145636526 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr4:145636526G>A ENST00000296575.3 + 10 2277 c.1622G>A c.(1621-1623)gGg>gAg p.G541E NM_022475.2 NP_071920.1 Q96QV1 HHIP_HUMAN hedgehog interacting protein 541 cytoplasm|extracellular region catalytic activity|protein binding|zinc ion binding central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(5)|liver(2)|lung(9)|ovary(2)|pancreas(1)|prostate(1)|skin(4)|upper_aerodigestive_tract(1) 33 all_hematologic(180;0.151) GBM - Glioblastoma multiforme(119;0.0185) GGCACTAGTGGGTCCTGTAGA 0.428000 15 33 0 0 1 0 0 B4GALT1 2683 broad.mit.edu 37 9 33135343 33135343 + Silent SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr9:33135343G>A ENST00000379731.4 - 2 678 c.492C>T c.(490-492)ggC>ggT p.G164G B4GALT1_ENST00000535206.1_Silent_p.G164G NM_001497.3 NP_001488.2 P15291 B4GT1_HUMAN UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 164 oligosaccharide biosynthetic process|post-translational protein modification|protein N-linked glycosylation via asparagine basolateral plasma membrane|brush border membrane|desmosome|external side of plasma membrane|extracellular region|glycocalyx|Golgi cisterna membrane|Golgi trans cisterna|integral to membrane alpha-tubulin binding|beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity|beta-tubulin binding|lactose synthase activity|metal ion binding|N-acetyllactosamine synthase activity|protein binding|protein homodimerization activity endometrium(1)|large_intestine(7)|lung(4)|prostate(1)|skin(1) 14 LUSC - Lung squamous cell carcinoma(29;0.0084) GBM - Glioblastoma multiforme(74;0.121) N-Acetyl-D-glucosamine(DB00141) CATAGCGGCCGCCCATCTTCA 0.557000 12 32 0 0 1 0 0 KCNK10 54207 broad.mit.edu 37 14 88652226 88652226 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr14:88652226G>A ENST00000340700.5 - 7 1721 c.1270C>T c.(1270-1272)Cgc>Tgc p.R424C KCNK10_ENST00000312350.5_Missense_Mutation_p.R429C|KCNK10_ENST00000319231.5_Missense_Mutation_p.R429C NM_021161.4 NP_066984.1 P57789 KCNKA_HUMAN potassium channel, subfamily K, member 10 424 signal transduction integral to membrane potassium channel activity|voltage-gated ion channel activity breast(1)|central_nervous_system(1)|endometrium(1)|kidney(2)|large_intestine(5)|lung(25)|ovary(3)|pancreas(2)|prostate(2)|skin(4)|upper_aerodigestive_tract(1) 47 CCCTTCAGGCGCAGGTTGTTG 0.607000 19 39 0 0 1 0 0 F7 2155 broad.mit.edu 37 13 113770051 113770051 + Missense_Mutation SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr13:113770051C>T ENST00000375581.3 + 6 543 c.508C>T c.(508-510)Cgc>Tgc p.R170C F7_ENST00000346342.3_Missense_Mutation_p.R148C|F7_ENST00000541084.1_Missense_Mutation_p.R101C NM_000131.4 NP_000122.1 P08709 FA7_HUMAN coagulation factor VII (serum prothrombin conversion accelerator) 170 EGF-like 2. anti-apoptosis|blood coagulation, extrinsic pathway|peptidyl-glutamic acid carboxylation|positive regulation of leukocyte chemotaxis|positive regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of positive chemotaxis|positive regulation of protein kinase B signaling cascade|post-translational protein modification|proteolysis endoplasmic reticulum lumen|Golgi lumen|plasma membrane calcium ion binding|glycoprotein binding|serine-type endopeptidase activity large_intestine(4)|lung(9)|ovary(1)|prostate(1)|upper_aerodigestive_tract(1) 16 all_lung(23;0.000374)|Lung NSC(43;0.0107)|Lung SC(71;0.0753)|all_neural(89;0.0804)|Hepatocellular(20;0.0877)|Medulloblastoma(90;0.163) all_cancers(25;0.118)|all_lung(25;0.0364)|all_epithelial(44;0.0393)|Lung NSC(25;0.128)|Breast(118;0.188) all cancers(43;0.0737)|Epithelial(84;0.213)|BRCA - Breast invasive adenocarcinoma(86;0.218) Coagulation Factor IX(DB00100)|Coagulation factor VIIa(DB00036)|Menadione(DB00170) GGGCACCAAGCGCTCCTGTCG 0.617000 8 27 0 0 1 0 0 CACNG3 10368 broad.mit.edu 37 16 24373167 24373167 + Missense_Mutation SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr16:24373167C>T ENST00000005284.3 + 4 2133 c.931C>T c.(931-933)Cgc>Tgc p.R311C NM_006539.3 NP_006530.1 O60359 CCG3_HUMAN calcium channel, voltage-dependent, gamma subunit 3 311 regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|synaptic transmission alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|endocytic vesicle membrane|voltage-gated calcium channel complex voltage-gated calcium channel activity p.R311C(1) NS(2)|breast(1)|endometrium(4)|kidney(2)|large_intestine(10)|lung(13)|ovary(2)|prostate(4)|skin(2) 40 GBM - Glioblastoma multiforme(48;0.0809) GGCCAACAGGCGCACCACGCC 0.562000 13 41 0 0 1 0 0 CBLN4 140689 broad.mit.edu 37 20 54579018 54579018 + Silent SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr20:54579018C>T ENST00000064571.2 - 1 1510 c.210G>A c.(208-210)aaG>aaA p.K70K NM_080617.4 NP_542184.1 Q9NTU7 CBLN4_HUMAN cerebellin 4 precursor 70 C1q. cell junction|extracellular region|synapse endometrium(2)|large_intestine(1)|lung(10)|ovary(3)|pancreas(1) 17 Colorectal(105;0.202) AGAAGGCGACCTTGGAGTTGG 0.637000 36 104 0 0 1 0 0 SCAPER 49855 broad.mit.edu 37 15 77064287 77064287 + Silent SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr15:77064287C>T ENST00000538941.2 - 10 1245 c.306G>A c.(304-306)gtG>gtA p.V102V SCAPER_ENST00000324767.7_Silent_p.V348V|SCAPER_ENST00000563290.1_Silent_p.V348V NM_001145923.1 NP_001139395.1 Q9BY12 SCAPE_HUMAN S-phase cyclin A-associated protein in the ER 347 endoplasmic reticulum|nucleus zinc ion binding NS(1)|breast(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(8)|lung(16)|ovary(2)|prostate(2)|skin(1)|urinary_tract(2) 39 CCAATGTACTCACTGTGAACT 0.338000 7 28 0 0 1 0 0 LEP 3952 broad.mit.edu 37 7 127892092 127892092 + Silent SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr7:127892092C>T ENST00000308868.4 + 2 72 c.21C>T c.(19-21)tgC>tgT p.C7C NM_000230.2 NP_000221.1 P41159 LEP_HUMAN leptin 7 adult feeding behavior|energy reserve metabolic process|negative regulation of appetite|placenta development|positive regulation of developmental growth extracellular space endometrium(1)|large_intestine(2)|lung(5) 8 GAACCCTGTGCGGATTCTTGT 0.488000 19 87 0 0 1 0 0 RXRG 6258 broad.mit.edu 37 1 165389159 165389159 + Silent SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr1:165389159G>A ENST00000359842.5 - 3 692 c.390C>T c.(388-390)agC>agT p.S130S RXRG_ENST00000470566.1_5'UTR NM_001256570.1|NM_006917.4 NP_001243499.1|NP_008848.1 P48443 RXRG_HUMAN retinoid X receptor, gamma 130 Modulating (By similarity). regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor nucleoplasm retinoid-X receptor activity|sequence-specific DNA binding transcription factor activity|steroid binding|steroid hormone receptor activity|zinc ion binding endometrium(1)|kidney(3)|large_intestine(6)|lung(22)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(2) 38 all_hematologic(923;0.0773)|Acute lymphoblastic leukemia(8;0.155) Acitretin(DB00459)|Adapalene(DB00210)|Alitretinoin(DB00523)|Etretinate(DB00926)|Tretinoin(DB00755) GAGATCCGGGGCTGGTGGATG 0.522000 12 37 0 0 1 0 0 ADCY7 113 broad.mit.edu 37 16 50325794 50325794 + Missense_Mutation SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr16:50325794C>T ENST00000394697.2 + 4 863 c.523C>T c.(523-525)Cgg>Tgg p.R175W ADCY7_ENST00000537579.1_Missense_Mutation_p.R175W|ADCY7_ENST00000254235.3_Missense_Mutation_p.R175W|ADCY7_ENST00000564044.1_Intron|ADCY7_ENST00000566433.2_Missense_Mutation_p.R175W|ADCY7_ENST00000538642.1_Missense_Mutation_p.R175W P51828 ADCY7_HUMAN adenylate cyclase 7 175 activation of adenylate cyclase activity by G-protein signaling pathway|activation of phospholipase C activity|activation of protein kinase A activity|cellular response to ethanol|cellular response to glucagon stimulus|energy reserve metabolic process|inhibition of adenylate cyclase activity by G-protein signaling pathway|nerve growth factor receptor signaling pathway|positive regulation of cAMP biosynthetic process|synaptic transmission|transmembrane transport|water transport integral to membrane|plasma membrane adenylate cyclase activity|ATP binding|metal ion binding breast(1)|cervix(1)|endometrium(5)|large_intestine(6)|lung(14)|ovary(1)|prostate(1)|skin(2)|stomach(1)|urinary_tract(3) 35 all_cancers(37;0.0127) GBM - Glioblastoma multiforme(240;0.195) Bromocriptine(DB01200) ACCCAGTGTCCGGGTGGGGCT 0.652000 12 32 0 0 1 0 0 CBFA2T3 863 broad.mit.edu 37 16 88967963 88967963 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr16:88967963G>A ENST00000268679.4 - 2 649 c.253C>T c.(253-255)Cct>Tct p.P85S CBFA2T3_ENST00000360302.2_Missense_Mutation_p.P24S|CBFA2T3_ENST00000327483.5_Missense_Mutation_p.P24S|CBFA2T3_ENST00000436887.2_Missense_Mutation_p.P85S|CBFA2T3_ENST00000448839.1_Intron NM_005187.5 NP_005178.4 O75081 MTG16_HUMAN core-binding factor, runt domain, alpha subunit 2; translocated to, 3 85 Mediates interaction with PDE7A (in isoform 2).|Mediates localization to the nucleus (By similarity).|Pro-rich.|Required for nucleolar targeting (in isoform 1). cell proliferation|granulocyte differentiation Golgi membrane|nucleolus|nucleoplasm protein binding|sequence-specific DNA binding transcription factor activity|zinc ion binding endometrium(3)|kidney(2)|large_intestine(4)|lung(5)|ovary(1)|prostate(1)|upper_aerodigestive_tract(1) 17 BRCA - Breast invasive adenocarcinoma(80;0.0275) GATGCGGCAGGCGGTGGGGGC 0.701000 T RUNX1 AML 16 35 0 0 1 0 0 CALN1 83698 broad.mit.edu 37 7 71571179 71571179 + Silent SNP G G A rs139754746 TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr7:71571179G>A ENST00000395275.2 - 4 733 c.345C>T c.(343-345)agC>agT p.S115S CALN1_ENST00000329008.5_Silent_p.S73S|CALN1_ENST00000431984.1_Silent_p.S73S|CALN1_ENST00000395276.2_Silent_p.S73S|CALN1_ENST00000412588.1_Silent_p.S115S|CALN1_ENST00000405452.2_Silent_p.S73S NM_031468.3 NP_113656.2 Q9BXU9 CABP8_HUMAN calneuron 1 73 Golgi apparatus|integral to membrane|perinuclear region of cytoplasm|plasma membrane calcium ion binding biliary_tract(1)|breast(1)|endometrium(3)|large_intestine(6)|lung(19)|skin(2) 32 all_cancers(73;0.069)|Lung NSC(55;0.0658)|all_lung(88;0.0912)|all_epithelial(88;0.161) GCTCCACCTCGCTTGGCATGT 0.592000 10 33 0 0 1 0 0 PRICKLE4 29964 broad.mit.edu 37 6 41753227 41753227 + Silent SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr6:41753227C>T ENST00000359201.5 + 5 1120 c.531C>T c.(529-531)tgC>tgT p.C177C PRICKLE4_ENST00000458694.1_Silent_p.C177C|PRICKLE4_ENST00000394259.1_Silent_p.C137C|PRICKLE4_ENST00000394260.1_Silent_p.C137C|PRICKLE4_ENST00000394263.1_Silent_p.C177C Q2TBC4 PRIC4_HUMAN prickle homolog 4 (Drosophila) 137 LIM zinc-binding 2. nucleus zinc ion binding breast(1)|central_nervous_system(1)|endometrium(5)|kidney(1)|large_intestine(2)|lung(2)|ovary(1) 13 Ovarian(28;0.0355)|Colorectal(47;0.121) Epithelial(12;8.38e-05)|STAD - Stomach adenocarcinoma(11;0.000204)|Colorectal(64;0.00062)|COAD - Colon adenocarcinoma(64;0.00152) AACTCTACTGCGGCCGTCATC 0.622000 18 46 0 0 1 0 0 H3F3A 3020 broad.mit.edu 37 1 226252059 226252059 + Missense_Mutation SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr1:226252059C>T ENST00000366814.3 + 2 128 c.7C>T c.(7-9)Cgt>Tgt p.R3C H3F3A_ENST00000366816.1_Missense_Mutation_p.R3C|H3F3A_ENST00000366815.3_Missense_Mutation_p.R3C|H3F3A_ENST00000366813.1_Missense_Mutation_p.R3C H3 histone, family 3A p.R3C(1) central_nervous_system(116)|endometrium(2)|large_intestine(1)|lung(2)|upper_aerodigestive_tract(1)|urinary_tract(1) 123 Breast(184;0.179) GBM - Glioblastoma multiforme(131;0.203) TACCATGGCTCGTACAAAGCA 0.498000 Mis glioma OREG0014293 type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip) 12 18 0 0 1 0 0 EGFR 1956 broad.mit.edu 37 7 55211080 55211080 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr7:55211080G>A ENST00000275493.2 + 3 500 c.323G>A c.(322-324)aGa>aAa p.R108K EGFR_ENST00000454757.2_Missense_Mutation_p.R55K|EGFR_ENST00000420316.2_Missense_Mutation_p.R108K|EGFR_ENST00000455089.1_Missense_Mutation_p.R108K|EGFR_ENST00000342916.3_Missense_Mutation_p.R108K|EGFR_ENST00000344576.2_Missense_Mutation_p.R108K|EGFR_ENST00000442591.1_Missense_Mutation_p.R108K NM_005228.3 NP_005219.2 P00533 EGFR_HUMAN epidermal growth factor receptor 108 activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity p.R108K(6) NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6) 14110 all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318) GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607) Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072) CAGATCATCAGAGGAAATATG 0.423000 8 """A, O, Mis""" """glioma, NSCLC""" NSCLC Lung Cancer, Familial Clustering of TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08) 692 44 0 0 1 0 0 IGLV11-55 0 broad.mit.edu 37 22 22556480 22556480 + RNA SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr22:22556480G>A ENST00000390286.2 + 0 306 GTAACACAGCGTTTTTGCTCA 0.527000 16 41 0 0 1 0 0 CDCA7L 55536 broad.mit.edu 37 7 21956473 21956473 + Missense_Mutation SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr7:21956473C>T ENST00000406877.3 - 2 343 c.64G>A c.(64-66)Gat>Aat p.D22N CDCA7L_ENST00000373934.4_Missense_Mutation_p.D22N|CDCA7L_ENST00000465490.1_5'UTR|CDCA7L_ENST00000356195.5_5'UTR NM_018719.4 NP_061189.2 Q96GN5 CDA7L_HUMAN cell division cycle associated 7-like 22 positive regulation of cell proliferation|regulation of transcription, DNA-dependent|transcription, DNA-dependent cytoplasm|nucleolus NS(1)|breast(2)|central_nervous_system(1)|endometrium(3)|kidney(2)|large_intestine(8)|lung(8)|prostate(2)|skin(1)|urinary_tract(1) 29 TCTTCATCATCACTGGGGGCG 0.463000 30 130 0 0 1 0 0 PCDH11X 27328 broad.mit.edu 37 X 91133712 91133712 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chrX:91133712G>A ENST00000373094.1 + 2 3318 c.2473G>A c.(2473-2475)Gtt>Att p.V825I PCDH11X_ENST00000406881.1_Missense_Mutation_p.V825I|PCDH11X_ENST00000361724.1_Missense_Mutation_p.V825I|PCDH11X_ENST00000373088.1_Missense_Mutation_p.V825I|PCDH11X_ENST00000298274.8_Missense_Mutation_p.V825I|PCDH11X_ENST00000504220.1_Missense_Mutation_p.V825I|PCDH11X_ENST00000373097.1_Missense_Mutation_p.V825I|PCDH11X_ENST00000395337.2_Missense_Mutation_p.V825I|PCDH11X_ENST00000361655.2_Missense_Mutation_p.V825I NM_032968.3 NP_116750.1 Q9BZA7 PC11X_HUMAN protocadherin 11 X-linked 825 homophilic cell adhesion integral to plasma membrane calcium ion binding NS(1)|autonomic_ganglia(1)|biliary_tract(1)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(4)|large_intestine(30)|liver(4)|lung(92)|prostate(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(5)|urinary_tract(1) 159 CATAACTGTCGTTGTAGTTAT 0.463000 21 13 0 0 1 0 0 HSD17B7P2 0 broad.mit.edu 37 10 38654432 38654432 + RNA SNP A A G rs2257765 TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr10:38654432A>G ENST00000494540.1 + 0 599 NR_003086.1 TCATCTCGCAATGCAAGGAAA 0.453000 4 19 0 0 1 0 0 GSDMB 55876 broad.mit.edu 37 17 38073447 38073447 + Silent SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr17:38073447C>T ENST00000394175.2 - 1 346 c.123G>A c.(121-123)ggG>ggA p.G41G GSDMB_ENST00000360317.3_Silent_p.G41G|GSDMB_ENST00000309481.7_Silent_p.G41G|GSDMB_ENST00000520542.1_Silent_p.G41G|GSDMB_ENST00000394179.1_Silent_p.G41G|GSDMB_ENST00000418519.1_Silent_p.G41G NM_018530.2 NP_061000.2 Q8TAX9 GSDMB_HUMAN gasdermin B 41 cytoplasm breast(2)|endometrium(3)|large_intestine(6)|lung(6)|pancreas(1)|prostate(1)|stomach(2) 21 TTCTCTTCTCCCCCACCAGAT 0.483000 31 83 0 0 1 0 0 ACADS 35 broad.mit.edu 37 12 121176335 121176335 + Splice_Site SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr12:121176335G>A ENST00000242592.4 + 7 946 c.e7-1 ACADS_ENST00000411593.2_Splice_Site NM_000017.2 NP_000008.1 P16219 ACADS_HUMAN acyl-CoA dehydrogenase, C-2 to C-3 short chain mitochondrial matrix butyryl-CoA dehydrogenase activity central_nervous_system(3)|endometrium(1)|kidney(1)|large_intestine(1)|lung(5)|prostate(3) 14 all_neural(191;0.0684)|Medulloblastoma(191;0.0922) Lung NSC(355;0.163) NADH(DB00157) GGTCCCCACAGCAAACCCTGG 0.682000 10 34 0 0 1 0 0 IFITM1 8519 broad.mit.edu 37 11 314978 314978 + Silent SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr11:314978C>T ENST00000408968.3 + 2 561 c.243C>T c.(241-243)acC>acT p.T81T IFITM1_ENST00000328221.5_Silent_p.T81T|IFITM1_ENST00000528780.1_Silent_p.T81T NM_003641.3 NP_003632.3 P13164 IFM1_HUMAN interferon induced transmembrane protein 1 81 negative regulation of cell proliferation|regulation of immune response|response to virus|type I interferon-mediated signaling pathway integral to membrane|plasma membrane protein binding|receptor signaling protein activity large_intestine(1)|lung(3) 4 all_cancers(49;2e-09)|all_epithelial(84;3.36e-06)|Breast(177;0.000162)|Ovarian(85;0.000953)|Medulloblastoma(188;0.0109)|all_neural(188;0.0299)|Lung NSC(207;0.0538)|all_lung(207;0.0713) all cancers(45;8.85e-28)|Epithelial(43;5.52e-27)|OV - Ovarian serous cystadenocarcinoma(40;1.11e-20)|BRCA - Breast invasive adenocarcinoma(625;3.56e-05)|Lung(200;0.0327)|LUSC - Lung squamous cell carcinoma(625;0.122) ATGCCTCCACCGCCAAGTGCC 0.572000 16 51 0 0 1 0 0 PTEN 5728 broad.mit.edu 37 10 89624228 89624228 + Translation_Start_Site SNP T T A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr10:89624228T>A ENST00000371953.3 + 1 1359 c.2T>A c.(1-3)aTg>aAg p.M1K NM_000314.4 NP_000305.3 P60484 PTEN_HUMAN phosphatase and tensin homolog 1 activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway cytosol|internal side of plasma membrane|PML body anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity p.0?(37)|p.?(13)|p.M1fs*7(1)|p.M1fs*24(1)|p.M1T(1) NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17) 2771 all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132) KIRC - Kidney renal clear cell carcinoma(1;0.214) UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218) CTCCCAGACATGACAGCCATC 0.507000 31 """D, Mis, N, F, S""" """glioma, prostate, endometrial""" """harmartoma, glioma, prostate, endometrial""" Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18) 11 19 0 0 1 0 0 HEATR1 55127 broad.mit.edu 37 1 236744701 236744701 + Missense_Mutation SNP T T A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr1:236744701T>A ENST00000366582.3 - 20 2690 c.2576A>T c.(2575-2577)gAt>gTt p.D859V HEATR1_ENST00000366581.2_Missense_Mutation_p.D859V NM_018072.5 NP_060542.4 Q9H583 HEAT1_HUMAN HEAT repeat containing 1 859 rRNA processing nucleolus|ribonucleoprotein complex protein binding NS(2)|breast(7)|central_nervous_system(1)|endometrium(11)|haematopoietic_and_lymphoid_tissue(2)|kidney(4)|large_intestine(18)|lung(28)|ovary(3)|prostate(1)|skin(4)|stomach(3)|upper_aerodigestive_tract(3) 87 Ovarian(103;0.0634)|Breast(184;0.133) all_cancers(173;0.0255)|Prostate(94;0.175) OV - Ovarian serous cystadenocarcinoma(106;0.00117) CTGAAAAACATCTTCTAGATG 0.328000 9 39 0 0 1 0 0 PIK3R5 23533 broad.mit.edu 37 17 8794082 8794082 + Silent SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr17:8794082G>A ENST00000447110.1 - 7 754 c.630C>T c.(628-630)gaC>gaT p.D210D PIK3R5_ENST00000581552.1_Silent_p.D210D|PIK3R5_ENST00000584803.1_Silent_p.D210D NM_001142633.2|NM_001251851.1|NM_001251852.1|NM_001251853.1|NM_001251855.1 NP_001136105.1|NP_001238780.1|NP_001238781.1|NP_001238782.1|NP_001238784.1 Q8WYR1 PI3R5_HUMAN phosphoinositide-3-kinase, regulatory subunit 5 210 platelet activation cytosol|membrane|nucleus breast(2)|central_nervous_system(1)|endometrium(4)|kidney(2)|large_intestine(3)|lung(14)|prostate(3)|skin(4)|urinary_tract(1) 34 GGCCCGGGACGTCACAGTGGG 0.632000 3 13 0 0 1 0 0 ACKR2 1238 broad.mit.edu 37 3 42907140 42907140 + Silent SNP A A G TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr3:42907140A>G ENST00000422265.1 + 3 1321 c.1146A>G c.(1144-1146)aaA>aaG p.K382K ACKR2_ENST00000442925.1_Silent_p.K382K|CYP8B1_ENST00000437102.1_Intron|ACKR2_ENST00000273145.2_Silent_p.K382K|KRBOX1_ENST00000426937.1_Intron|ACKR2_ENST00000471537.1_Intron NM_001296.4 NP_001287.2 atypical chemokine receptor 2 TGGGGAATAAATCAGCCTGAG 0.502000 14 24 0 0 1 0 0 CRYBB2P1 0 broad.mit.edu 37 22 25855471 25855471 + RNA SNP C C T TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr22:25855471C>T ENST00000354451.2 + 0 355 CTTTGGGGCCCGTCACCCTCA 0.627000 12 38 0 0 1 0 0 NLRP1 22861 broad.mit.edu 37 17 5462410 5462410 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr17:5462410G>A ENST00000345221.3 - 4 2160 c.1606C>T c.(1606-1608)Cgg>Tgg p.R536W NLRP1_ENST00000269280.4_Missense_Mutation_p.R536W|NLRP1_ENST00000572272.1_Missense_Mutation_p.R536W|NLRP1_ENST00000571307.1_5'UTR|NLRP1_ENST00000262467.5_Missense_Mutation_p.R536W|NLRP1_ENST00000354411.3_Missense_Mutation_p.R536W|NLRP1_ENST00000577119.1_Missense_Mutation_p.R536W NM_014922.4|NM_033004.3|NM_033007.3 NP_055737.1|NP_127497.1|NP_127500.1 Q9C000 NALP1_HUMAN NLR family, pyrin domain containing 1 536 NACHT. defense response to bacterium|induction of apoptosis|neuron apoptosis|positive regulation of interleukin-1 beta secretion|response to muramyl dipeptide cytoplasm|NALP1 inflammasome complex|nucleus ATP binding|caspase activator activity|enzyme binding|protein domain specific binding breast(4)|central_nervous_system(1)|cervix(1)|endometrium(7)|kidney(2)|large_intestine(17)|liver(5)|lung(17)|ovary(1)|prostate(3)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 65 Colorectal(1115;3.48e-05) TTTTCCTTCCGCTTCATCTGC 0.547000 28 70 0 0 1 0 0 NTN4 59277 broad.mit.edu 37 12 96181099 96181099 + Missense_Mutation SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr12:96181099G>A ENST00000343702.4 - 2 651 c.203C>T c.(202-204)aCg>aTg p.T68M NTN4_ENST00000344911.4_Missense_Mutation_p.T31M|NTN4_ENST00000553059.1_Missense_Mutation_p.T68M|NTN4_ENST00000538383.1_Missense_Mutation_p.T31M NM_021229.3 NP_067052.2 Q9HB63 NET4_HUMAN netrin 4 68 Laminin N-terminal. T -> K (in Ref. 1; AAG30822). axon guidance basement membrane|plasma membrane NS(2)|breast(1)|kidney(1)|large_intestine(7)|lung(8)|ovary(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(1) 25 AGTCAGATCCGTGTTCTCACT 0.537000 11 39 0 0 1 0 0 PDK1 5163 broad.mit.edu 37 2 173431601 173431601 + Missense_Mutation SNP A A T rs148646668 TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr2:173431601A>T ENST00000410055.1 + 6 809 c.709A>T c.(709-711)Agg>Tgg p.R237W PDK1_ENST00000392571.2_Missense_Mutation_p.R257W|PDK1_ENST00000282077.2_Missense_Mutation_p.R237W|PDK1_ENST00000544863.1_Missense_Mutation_p.R82W|PDK1_ENST00000543905.1_Missense_Mutation_p.R161W NM_002610.3 NP_002601.1 Q15118 PDK1_HUMAN pyruvate dehydrogenase kinase, isozyme 1 237 Histidine kinase. glucose metabolic process|peptidyl-histidine phosphorylation|pyruvate metabolic process|regulation of acetyl-CoA biosynthetic process from pyruvate|small GTPase mediated signal transduction mitochondrial matrix ATP binding|pyruvate dehydrogenase (acetyl-transferring) kinase activity|two-component sensor activity central_nervous_system(2)|kidney(1)|large_intestine(2)|lung(8)|ovary(2)|prostate(1) 16 OV - Ovarian serous cystadenocarcinoma(117;0.12) TGAAAATGCTAGGCGTCTGTG 0.323000 Autosomal Dominant Polycystic Kidney Disease 3 16 0 0 1 0 0 SPATA31C1 0 broad.mit.edu 37 9 90535986 90535986 + RNA SNP G G A TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr9:90535986G>A ENST00000602681.1 + 0 1890 GCCCTGCGTCGCAGAATAAAG 0.517000 52 158 0 0 1 0 0 SEL1L3 23231 broad.mit.edu 37 4 25835187 25835188 + Frame_Shift_Del DEL TA TA - TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr4:25835187_25835188delTA ENST00000399878.3 - 4 986_987 c.864_865delTA c.(862-867)ttctfs p.FT288fs SEL1L3_ENST00000502949.1_Frame_Shift_Del_p.FT135fs|SEL1L3_ENST00000264868.5_Frame_Shift_Del_p.FT253fs|SEL1L3_ENST00000513364.1_5'UTR NM_015187.3 NP_056002.2 Q68CR1 SE1L3_HUMAN sel-1 suppressor of lin-12-like 3 (C. elegans) 288 integral to membrane binding breast(1)|endometrium(1)|kidney(2)|large_intestine(1)|lung(6)|prostate(1)|urinary_tract(2) 14 AATGAAACAGTAAACCTATAAG 0.376 2 4 --- --- --- --- RABEPK 10244 broad.mit.edu 37 9 127996226 127996226 + Frame_Shift_Del DEL C C - TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr9:127996226delC ENST00000373538.3 + 8 1396 c.1086delC c.(1084-1086)atfs p.I362fs RABEPK_ENST00000259460.8_Frame_Shift_Del_p.I311fs|RABEPK_ENST00000394124.4_3'UTR|RABEPK_ENST00000394125.4_Frame_Shift_Del_p.I362fs NM_005833.3 NP_005824.2 Q7Z6M1 RABEK_HUMAN Rab9 effector protein with kelch motifs 362 receptor-mediated endocytosis|vesicle docking involved in exocytosis endosome membrane|plasma membrane NS(1)|cervix(1)|endometrium(1)|large_intestine(2)|lung(3)|ovary(2)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1) 15 AAGGGGAAATCTATGACGATT 0.388 32 90 --- --- --- --- PLCE1 51196 broad.mit.edu 37 10 96053387 96053387 + Frame_Shift_Del DEL T T - TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr10:96053387delT ENST00000260766.3 + 23 5792 c.5158delT c.(5158-5160)ctfs p.S1720fs PLCE1_ENST00000371380.2_Frame_Shift_Del_p.S1720fs|PLCE1_ENST00000371385.3_Frame_Shift_Del_p.S1412fs|PLCE1_ENST00000371375.1_Frame_Shift_Del_p.S1412fs NM_016341.3 NP_057425.3 Q9P212 PLCE1_HUMAN phospholipase C, epsilon 1 1720 Required for activation by RHOA, RHOB, GNA12, GNA13 and G-beta gamma (By similarity). activation of MAPK activity|activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger|activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway|calcium-mediated signaling|cell proliferation|cytoskeleton organization|diacylglycerol biosynthetic process|elevation of cytosolic calcium ion concentration|epidermal growth factor receptor signaling pathway|glomerulus development|heart development|lipid catabolic process|Ras protein signal transduction|regulation of cell growth|regulation of G-protein coupled receptor protein signaling pathway|regulation of Ras protein signal transduction|regulation of smooth muscle contraction cytosol|Golgi membrane|membrane fraction|plasma membrane calcium ion binding|guanyl-nucleotide exchange factor activity|phosphatidylinositol phospholipase C activity|Ras GTPase binding|receptor signaling protein activity liver(1)|ovary(2)|skin(4)|upper_aerodigestive_tract(1) 8 Colorectal(252;0.0458) TAACAAAACATCTGGAAAAAG 0.388 11 25 --- --- --- --- MESP2 145873 broad.mit.edu 37 15 90320121 90320144 + In_Frame_Del DEL AGGGGCAGGGGCAAGGGCAGGGGC AGGGGCAGGGGCAAGGGCAGGGGC - rs56192595 TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr15:90320121_90320144delAGGGGCAGGGGCAAGGGCAGGGGC ENST00000341735.3 + 1 533_556 c.533_556delAGGGGCAGGGGCAAGGGCAGGGGC c.(532-558)gag>g p.EGQGQGQGQ178del MESP2_ENST00000560219.1_Intron|MESP2_ENST00000558723.1_Intron NM_001039958.1 NP_001035047.1 Q0VG99 MESP2_HUMAN mesoderm posterior 2 homolog (mouse) 178 Notch signaling pathway nucleus DNA binding p.Q198_G205delQGQGQGQG(1) kidney(1)|large_intestine(2)|lung(1)|skin(1)|upper_aerodigestive_tract(1) 6 Lung NSC(78;0.0221)|all_lung(78;0.0448) BRCA - Breast invasive adenocarcinoma(143;0.0146)|KIRC - Kidney renal clear cell carcinoma(17;0.0286)|Kidney(142;0.0514) ACGCaggcggaggggcaggggcaagggcaggggcaggggcaggg 0.777 3 4 --- --- --- --- AC126365.1 0 broad.mit.edu 37 17 20623668 20623669 + RNA DEL TT TT - rs151078009 TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr17:20623668_20623669delTT ENST00000578210.1 + 0 150 NR_073509.1 gcccggctaatttttttttttt 0.574 3 6 --- --- --- --- POLDIP2 26073 broad.mit.edu 37 17 26684394 26684395 + Splice_Site INS - - G rs113730440 TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr17:26684394_26684395insG ENST00000540200.1 - 1 78 c.e1+1 POLDIP2_ENST00000003607.4_5'UTR NM_015584.3 NP_056399.1 Q9Y2S7 PDIP2_HUMAN polymerase (DNA-directed), delta interacting protein 2 mitochondrial nucleoid|nucleus all_lung(13;0.000354)|Lung NSC(42;0.00115) UCEC - Uterine corpus endometrioid carcinoma (53;0.154) AGAGCGGCTTTGCCACCGGGCC 0.762 3 4 --- --- --- --- LRRC37A11P 0 broad.mit.edu 37 17 37200857 37200857 + RNA DEL A A - TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr17:37200857delA ENST00000425901.2 + 0 2902 NR_033753.2 ACTGCCAAAGAAAAAAAGGCT 0.592 2 4 --- --- --- --- P2RX6 9127 broad.mit.edu 37 22 21380124 21380124 + Frame_Shift_Del DEL T T - TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6dbc06d4-1ab9-42f1-afd6-dd23af867c55 b325a96a-ae13-4143-a715-7e57b29f83ad g.chr22:21380124delT ENST00000413302.2 + 9 1069 c.921delT c.(919-921)ggfs p.G307fs P2RX6_ENST00000401443.1_Frame_Shift_Del_p.G281fs|P2RX6_ENST00000336296.2_Frame_Shift_Del_p.G297fs|P2RX6_ENST00000402329.3_3'UTR|P2RX6_ENST00000443995.3_Frame_Shift_Del_p.G254fs O15547 P2RX6_HUMAN purinergic receptor P2X, ligand-gated ion channel, 6 307 muscle contraction|protein homooligomerization cell junction|cytoplasm|integral to plasma membrane ATP binding|extracellular ATP-gated cation channel activity|identical protein binding|purinergic nucleotide receptor activity AGCAACCGGGTGTGGAGGCCC 0.657 2 4 --- --- --- ---